• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number CEB231010A
Device Problem Compatibility Problem (2960)
Patient Problem Aneurysm (1708)
Event Date 08/23/2019
Event Type  Injury  
Manufacturer Narrative
According to the instructions for use (ifu) for the gore® excluder® iliac branch endoprostheses; adverse events that may occur include, but are not limited to include: endoleak a review of the manufacturing records for the device(s) verified that the lot(s) met all pre-release specifications.
 
Event Description
On (b)(6) 2019, this patient underwent endovascular treatment for an abdominal aortic aneurysm, a right common iliac artery aneurysm and a left internal iliac artery aneurysm (liia) and was implanted with gore® excluder® aaa endoprostheses and gore® excluder® iliac branch endoprostheses.Additionally, coil embolization of the left internal iliac artery was performed.On an unknown date one week later, estimated to be on or about (b)(6) 2019, follow-up examination revealed a type iii endoleak around right contralateral leg endoprosthesis.On (b)(6) 2019, the patient underwent re-intervention to treat the type iii endoleak.It was determined that the type iii endoleak was from a suspected disconnect of the contralateral leg component used as the bridge graft to the iliac branch component (ibc).An a additional stent graft was implanted to reline the overlap zone of the bridge graft and the ibc.The type iii endoleak was resolved however angiography revealed a type ii endoleak from the origin of a lumbar artery.The patient tolerated the procedure and the type ii endoleak will be monitored by the physician.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SILICON VALLEY B/P
2890 de la cruz blvd.
santa clara CA 95050
Manufacturer Contact
laura crawford
1500 n. 4th street
9285263030
MDR Report Key9097368
MDR Text Key159331269
Report Number3013164176-2019-00119
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132635283
UDI-Public00733132635283
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/10/2022
Device Catalogue NumberCEB231010A
Device Lot Number20466572
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/20/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/11/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age81 YR
-
-